Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients (Q47196323)

http://europepmc.org/abstract/PMC/5759886

19 February 2018

title

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients (English)

1 reference

http://europepmc.org/abstract/PMC/5759886

19 February 2018

main subject

triple-negative breast cancer

1 reference

inferred from title

author

Silvana Anna Maria Urru

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Silvano Gallus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Cristina Bosetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Matteo Floris

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Francesco Atzori

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Maurizio D'Incalci

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

15

Ciriaco Carru

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Tiziana Moi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ricardo Medda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Elisabetta Sollai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Alma Murgia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Francesca Sanges

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Giovanna Pira

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Alessandra Manca

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Dolores Palmas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Anna Maria Asunis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Massimo Ghiani

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Vincenzo Marras

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Daniela Onnis

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Maria Cristina Santona

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Giuseppina Sarobba

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Enrichetta Valle

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Luisa Canu

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sergio Cossu

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Alessandro Bulfone

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paolo Cossu Rocca

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Maria Rosaria De Miglio

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sandra Orrù

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

8 January 2018

1 reference

http://europepmc.org/abstract/PMC/5759886

19 February 2018

published in

BMC Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer

2 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

The Global Burden of Cancer 2013

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Ki67--no evidence for its use in node-positive breast cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Estimates of cancer burden in Sardinia.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Triple-negative breast cancer: epidemiological considerations and recommendations

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Triple negative breast cancer - prognostic factors and survival

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Triple-Negative Breast Cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Breast cancer prognostic classification in the molecular era: the role of histological grade

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Ki67 in breast cancer: prognostic and predictive potential

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Triple-negative breast cancer: clinical features and patterns of recurrence

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Triple negative breast cancer: clinical characteristics in the different histological subtypes.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Clinical relevance of TNM staging system according to breast cancer subtypes.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

14 August 2018

2 references

Crossref

https://api.crossref.org/works/10.1186%2FS12885-017-3969-Y

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5759886

Lymph node ratio as an alternative to pN staging in node-positive breast cancer

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29310602

12 December 2020

inferred from PubMed ID database lookup

Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29310602

12 December 2020

inferred from PubMed ID database lookup

The prognostic significance of lymphovascular invasion in invasive breast carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29310602

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/S12885-017-3969-Y

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 June 2020

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/s12885-017-3969-y

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29310602%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

29310602

1 reference